Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip.
Product Approval Dates
01‐MAR‐1985 Human Immunodeficiency Virus Type 1 (HIV‐1/EnzymeImmuno Assay (EIA), Dried Blood Spot/Lysate)
01‐MAR‐1985 Human Immunodeficiency Virus Type 1 (HIV‐1/EnzymeImmuno Assay (EIA)/Lysate)
05‐APR‐1974 Antibody to Hepatitis B Surface Antigen Reversed Passive Hemagglutination (RPHA) (Antibody to HBsAg/Other/Other)
11‐JUL‐2007 Hepatitis C Virus Encoded Antigens (Recombinant c100‐3, HCr43, NS5)
13‐JUL‐1990 Hepatitis C Virus Encoded Antigen (HCV Encoded Antigen/Enzyme Immuno Assay (EIA)/Recombinant)
13‐OCT‐2005 Hepatitis B Virus Core Antigen (E.coli, Recombinant)
15‐MAR‐1971 Antibody to Hepatitis B Surface Antigen (Antibody to HBsAg/Radio Immuno Assay (RIA)/Lysate)
16‐JAN‐2008 Human T‐Lymphotropic Virus Types I & II
18‐JUL‐2006 Antibody to Hepatitis B Surface Antigen (Mouse Monoclonal IgM) and Antibody to Hepatitis B Surface Antigen (Human)
18‐SEP‐2009 Human Immunodeficiency Virus Types 1 and 2 (E. oli, B. megaterium, Recombinant) Antigen and Synthetic Peptide
21‐JUN‐1999 Hepatitis B Surface Antigen (FA03) (HBsAg/Enzyme Immuno Assay (EIA)/Recombinant)
29‐NOV‐1988 Human T‐Lymphotropic Virus Type I (HTLV‐I/Enzyme Immuno Assay (EIA), Version 2.0/Lysate)
29‐NOV‐1988 Human T‐Lymphotropic Virus Type I (HTLV‐I/Enzyme Immuno Assay (EIA)/Lysate)
30‐APR‐2010 Trypanosoma cruzi (E. coli, Recombinant) Antigen